Representative Julie Johnson (D-Texas) recently bought shares of Danaher Corporation (NYSE:DHR). In a filing disclosed on November 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in Danaher stock on October 7th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.
Representative Julie Johnson also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 10/31/2025.
- Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/31/2025.
- Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/27/2025.
- Sold $1,001 – $15,000 in shares of Deere & Company (NYSE:DE) on 10/22/2025.
- Sold $1,001 – $15,000 in shares of Alaska Air Group (NYSE:ALK) on 10/22/2025.
- Sold $1,001 – $15,000 in shares of Weyerhaeuser (NYSE:WY) on 10/22/2025.
- Sold $1,001 – $15,000 in shares of F5 (NASDAQ:FFIV) on 10/22/2025.
- Sold $1,001 – $15,000 in shares of Gen Digital (NASDAQ:GEN) on 10/22/2025.
- Sold $1,001 – $15,000 in shares of The PNC Financial Services Group (NYSE:PNC) on 10/21/2025.
- Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/21/2025.
Danaher Price Performance
Shares of DHR stock opened at $225.75 on Wednesday. The stock’s 50-day moving average is $206.70 and its 200 day moving average is $201.47. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market cap of $159.46 billion, a P/E ratio of 46.55, a PEG ratio of 3.28 and a beta of 0.81.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.
Wall Street Analyst Weigh In
Several research firms recently commented on DHR. Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. UBS Group reduced their price target on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. TD Cowen upped their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Guggenheim reissued a “buy” rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.
Read Our Latest Report on Danaher
Institutional Trading of Danaher
Large investors have recently made changes to their positions in the business. Pacific Capital Partners Ltd purchased a new position in shares of Danaher during the 1st quarter valued at about $7,175,000. Larson Financial Group LLC boosted its stake in shares of Danaher by 154.1% in the first quarter. Larson Financial Group LLC now owns 5,517 shares of the conglomerate’s stock worth $1,131,000 after buying an additional 3,346 shares during the last quarter. Allen Capital Group LLC grew its holdings in Danaher by 38.7% during the first quarter. Allen Capital Group LLC now owns 2,059 shares of the conglomerate’s stock worth $422,000 after acquiring an additional 574 shares during the period. Mayflower Financial Advisors LLC raised its position in Danaher by 12.3% during the first quarter. Mayflower Financial Advisors LLC now owns 2,846 shares of the conglomerate’s stock valued at $583,000 after acquiring an additional 312 shares in the last quarter. Finally, Montis Financial LLC raised its position in Danaher by 14.5% during the first quarter. Montis Financial LLC now owns 1,756 shares of the conglomerate’s stock valued at $360,000 after acquiring an additional 223 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. This trade represents a 66.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 29,728 shares of company stock worth $6,448,990. Corporate insiders own 11.10% of the company’s stock.
About Representative Johnson
Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.
Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
